First Turn Management »

Bicara Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.0M 346k 17.42
2024-09-30 $14M 562k 25.47

More positions owned by First Turn Management

Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
United Therapeutics Corporation (UTHR)
Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Bridgebio Pharma (BBIO)
Revolution Medicines (RVMD)
Ascendis Pharma A/s Sponsored Adr (ASND)
Argenx Se Sponsored Adr (ARGX)
Disc Medicine (IRON)
Oric Pharmaceuticals (ORIC)
Arcellx Common Stock (ACLX)
Neurocrine Biosciences (NBIX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for First Turn Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics